series-c-plus
Stage
1
Investors
About
Promedior is a clinical-stage biotechnology company developing targeted therapeutics to treat diseases involving fibrosis, including severe fibrotic and inflammatory conditions such as idiopathic pulmonary fibrosis (IPF).
Explore Promedior's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.